Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥972m2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥2.6bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥993m2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥56m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥69m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥53m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥387m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥88m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥39m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥112m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥25m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥327m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥76m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥25m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥76m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥4.4bnat 2024-09-30Cons.Assets
Total assets¥5.2bnat 2024-03-31Cons.Assets
Total assets¥4.5bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥907mat 2024-09-30Cons.Liabilities
Total liabilities¥1.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥3.5bnat 2024-09-30Cons.Net assets
Net assets / equity¥3.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥3.4bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥1.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥157m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥399m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥174m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥247m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥89m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥40m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥154m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥146m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥140m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥18.552024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥238.992023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥55.772023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio79.6%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.9%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.2%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥375m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥375m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥37m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥353m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥353m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥100m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2024-04-01 → 2024-09-30¥244m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2024-04-01 → 2024-09-30¥244m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2024-04-01 → 2024-09-30¥70m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥972m
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥972m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥207m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥332m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥332m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥9m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥345m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥345m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥103m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2023-04-01 → 2023-09-30¥317m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2023-04-01 → 2023-09-30¥317m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2023-04-01 → 2023-09-30¥110m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥993m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥993m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥222m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 432
ItemContextValueUnit
Income taxesPrior1YTDDuration36096000JPY
Income taxesCurrentYTDDuration13934000JPY
Profit lossPrior1YTDDuration76304000JPY
Profit lossCurrentYTDDuration25378000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-JPY
Profit loss attributable to owners of parentPrior1YTDDuration76304000JPY
Profit loss attributable to owners of parentCurrentYTDDuration25378000JPY
Profit lossPrior1YTDDuration76304000JPY
Profit lossCurrentYTDDuration25378000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration9330000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-11523000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration7774000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration-5616000JPY
Other comprehensive incomePrior1YTDDuration17104000JPY
Other comprehensive incomeCurrentYTDDuration-17140000JPY
Comprehensive incomePrior1YTDDuration93409000JPY
Comprehensive incomeCurrentYTDDuration8238000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration93409000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration8238000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration112401000JPY
Income before income taxesCurrentYTDDuration39313000JPY
Depreciation and amortization ope cfPrior1YTDDuration30480000JPY
Depreciation and amortization ope cfCurrentYTDDuration29316000JPY
Interest and dividends income ope cfPrior1YTDDuration-2843000JPY
Interest and dividends income ope cfCurrentYTDDuration-4461000JPY
Interest expenses ope cfPrior1YTDDuration133000JPY
Interest expenses ope cfCurrentYTDDuration70000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration-10656000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration10915000JPY
Loss gain on cancellation of insurance contract ope cfPrior1YTDDuration-24026000JPY
Loss gain on cancellation of insurance contract ope cfCurrentYTDDuration-JPY
Loss on retirement of property plant and equipment ope cfPrior1YTDDuration0JPY
Loss on retirement of property plant and equipment ope cfCurrentYTDDuration14027000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration253904000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration350582000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-195904000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-30978000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration92462000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-326716000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration-64013000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration-87039000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration-3268000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration-12710000JPY
Other net ope cfPrior1YTDDuration-23007000JPY
Other net ope cfCurrentYTDDuration-30773000JPY
Subtotal ope cfPrior1YTDDuration165660000JPY
Subtotal ope cfCurrentYTDDuration-48453000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass